Pneumococcal Vaccines

Infectious Disease·MeSH: Pneumonia

14 drugs in development·1 company·6 clinical trials

Drug Pipeline by Phase

Phase 3(8)

Drug	Company
0.5 mL dose of PCV20	Vaxcyte, Inc. (PCVX)
20 valent pneumococcal conjugate vaccine	Vaxcyte, Inc. (PCVX)
31 valent pneumococcal conjugate vaccine	Vaxcyte, Inc. (PCVX)
31-valent pneumococcal conjugate vaccine	Vaxcyte, Inc. (PCVX)
PCV20	Vaxcyte, Inc. (PCVX)
PCV21	Vaxcyte, Inc. (PCVX)
Seasonal Influenza Vaccine	Vaxcyte, Inc. (PCVX)
vax-31	Vaxcyte, Inc. (PCVX)

Phase 2(6)

BioSniper tracks 14 drugs in development for Pneumococcal Vaccines across 1 company.

There are 6 clinical trials targeting Pneumococcal Vaccines tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.